Evidence map›Paper›PMID 34482462›Full record

ArticleEnvironmental science and pollution research international2022

Nanocurcumin alleviates inflammation and oxidative stress in LPS-induced mastitis via activation of Nrf2 and suppressing TLR4-mediated NF-κB and HMGB1 signaling pathways in rats.

Mohamed A Lebda, Ingi H Elmassry, Nabil M Taha, Mohamed S Elfeky

Abstract read
PubMed Publisher
In one paragraph

Article in Environmental science and pollution research international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
5.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Metabolites Profiling and Bioassays RevealAntioxidants (Basel, Switzerland) · 2023
    Article
  10. Review
  11. The Link Between 15-FFrontiers in veterinary science · 2022
    Article
  12. Targeting AhR as a Novel Therapeutic Modality against Inflammatory Diseases.International journal of molecular sciences · 2021
    Review
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Mohamed A LebdaDepartment of Biochemistry, Faculty of Veterinary Medicine, Alexandria University, Alexandria, Egypt. lebdam1979@alexu.edu.eg.
Ingi H ElmassryDepartment of Biochemistry, Faculty of Veterinary Medicine, Alexandria University, Alexandria, Egypt.
Nabil M TahaDepartment of Biochemistry, Faculty of Veterinary Medicine, Alexandria University, Alexandria, Egypt.
Mohamed S ElfekyDepartment of Biochemistry, Faculty of Veterinary Medicine, Alexandria University, Alexandria, Egypt.
Alexandria University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coliform mastitis is a worldwide serious disease of the mammary gland. Curcumin is a pleiotropic polyphenol obtained from turmeric, but it is hydrophobic and rapidly eliminated from the body. However, nanoformulation of curcumin significantly improves its pharmacological activity by enhancing its hydrophobicity and oral bioavailability. Our study aimed to investigate the possible antioxidant and anti-inflammatory effects of nanocurcumin as a prophylactic against LPS-induced coliform mastitis in rat model, where LPS was extracted from a field strain of Escherichia coli (bovine mastitis isolate). The study was conducted on twenty lactating Wistar female rats divided into four equal groups, and the mastitis model was initiated by injection of LPS through the duct of the mammary gland. The results showed that nanocurcumin significantly attenuated the lipid peroxidation (MDA), oxidized glutathione, the release of pro-inflammatory cytokines (TNF-α and IL-1β), and the gene expression of TLR4, NF-κB p65, and HMGB1. Meanwhile, it improved the reduced glutathione level and Nrf2 activity and preserved the normal alveolar architecture. These findings suggested that nanocurcumin supplementation can be a promising potential protective approach for coliform mastitis.

Indexed as

HMGB1 ProteinMastitisAnimalsCattleFemaleHumansInflammationLactationLipopolysaccharidesNF-E2-Related Factor 2NF-kappa BOxidative StressRatsRats, WistarSignal TransductionToll-Like Receptor 4HMGB1 ProteinLipopolysaccharidesNF-E2-Related Factor 2NF-kappa BTLR4 protein, humanTlr4 protein, ratToll-Like Receptor 4LPSMastitisNanocurcuminOxidative stressTLR4

Identifiers

PMID34482462
OpenAlexW3163835443

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.